GDUFA III Reauthorization Negotiation Sessions

In accordance with the Federal Food, Drug, and Cosmetic Act (FD&C Act), the Food and Drug Administration (FDA) held negotiations with the generic drug industry on the reauthorization of the Generic Drug User Fee Amendments of 2017 (GDUFA) program. The FDA publishes all negotiation meeting minutes on this website.

FDA-Industry Negotiations Meeting Minutes

September 17, 2020 Session (PDF - 22 KB)
October 1, 2020 Session (PDF - 12 KB)
October 15, 2020 Session (PDF - 12 KB)
October 22, 2020 Session (PDF - 85 KB)
October 29, 2020 Session (PDF - 16 KB)
November 12, 2020 Session PDF - 17 KB)
November 19, 2020 Session (PDF - 23 KB)
December 3, 2020 Session (PDF - 14 KB)
December 10, 2020 Session (PDF - 50 KB)
December 17, 2020 Session (PDF - 16 KB)
January 14, 2021 Session (PDF - 16 KB)
January 21, 2021 Session (PDF - 22 KB)
January 28, 2021 Session (PDF - 12 KB)
February 4, 2021 Session (PDF - 11 KB)
February 18, 2021 Session (PDF - 18 KB)
February 25, 2021 Session (PDF - 18 KB)
March 11, 2021 Session (PDF - 22 KB)
March 18, 2021 Session (PDF - 17 KB)
March 25, 2021 Session (PDF - 23 KB)
April 1, 2021 Session (PDF - 18 KB)
April 8, 2021 Session (PDF - 12 KB)
April 15, 2021 Session (PDF - 17 KB)
April 22, 2021 Session (PDF - 22 KB)
May 6, 2021 Session (PDF - 53 KB)
May 13, 2021 Session (PDF - 53 KB)
May 20, 2021 Session (PDF - 17 KB)